67.26KUSD
Type
Common Stock
Exchange
AMEX
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US42237K4094
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.02
Dividend Share
-
Dividend Yield
-
Earnings Share
-4.18
Wall Street Target Price
5.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,716,405
Gross Profit TTM
-10,545,513
EBITDA
-21,761,466
Profit Margin
0.00%
Return On Assets TTM
-47.94%
Return On Equity TTM
-303.40%
Revenue Per Share TTM
0.058
Qtly Revenue Growth YOY
-75.10%
Diluted Eps TTM
-4.18
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0392
Price Book MRQ
0.1068
Enterprise Value Revenue
10
Enterprise Value EBITDA
0
162.99
3.31%19.00
3.20%73.75
1.89%609.94
0.33%900.00
0.00%294.83
-1.87%278.09
-1.64%877.72
-1.63%451.63
-1.60%143.13
-0.66%